Bionano Genomics Inc
NASDAQ:BNGO
Bionano Genomics Inc
Cash from Financing Activities
Bionano Genomics Inc
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Bionano Genomics Inc
NASDAQ:BNGO
|
Cash from Financing Activities
$113.8m
|
CAGR 3-Years
23%
|
CAGR 5-Years
26%
|
CAGR 10-Years
N/A
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Cash from Financing Activities
-$3.6B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
Danaher Corp
NYSE:DHR
|
Cash from Financing Activities
-$144m
|
CAGR 3-Years
67%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
17%
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Cash from Financing Activities
-$859.6m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
-13%
|
|
Agilent Technologies Inc
NYSE:A
|
Cash from Financing Activities
-$1.2B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-8%
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Cash from Financing Activities
-$382m
|
CAGR 3-Years
-21%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
See Also
What is Bionano Genomics Inc's Cash from Financing Activities?
Cash from Financing Activities
113.8m
USD
Based on the financial report for Dec 31, 2023, Bionano Genomics Inc's Cash from Financing Activities amounts to 113.8m USD.
What is Bionano Genomics Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
26%
Over the last year, the Cash from Financing Activities growth was 395%. The average annual Cash from Financing Activities growth rates for Bionano Genomics Inc have been 23% over the past three years , 26% over the past five years .